Dear Friends,
Every day our philanthropic community supports a relentless commitment to possibilities in cancer care at Dana-Farber—and that gives me hope. Consider the extraordinary impact your generous donations have had on the lives of people touched by cancer. You support groundbreaking research and cancer-defying treatments that have been life changing. Even in times of uncertainty, your partnership in our work steadies us with support that ensures we can continue advancing transformative care for all our patients.
The network of families who’ve bravely navigated the journey from diagnosis to promising treatments in partnership with Dana-Farber physicians and researchers inspire us to advance cancer patient care. Fundraisers, physician-scientists, and researchers have collaborated to reach milestones. Dedicated donors, like the Janower family, who appear on the cover of this issue and are featured in this issue, have relentlessly supported Dana-Farber pediatric oncology breakthroughs. With their indefatigable spirit, combined with the determination of Dana-Farber physician-scientists and fueled by the powerful PMC community, and their personal philanthropy, accelerated the development of the first FDA-approved drug for a common form of pediatric cancer bringing hope through innovative cancer treatment to children around the world.
I believe that at the heart of every breakthrough is a Dana-Farber community rooted in possibility. With milestones met, Dana-Farber’s Future Cancer Hospital is moving forward and will ensure expert, world-class cancer care not only continues but expands its reach. This is an exciting moment as we reimagine a future of care that enhances the inpatient experience. Thanks to meaningful partnerships we will continue to build the storied legacy of the Dana-Farber Cancer Institute, pursuing a future brimming with hope for every cancer patient within our community.
Sincerely,
Melany N. Duval
Senior Vice President and Chief Philanthropy Officer